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Background
There are different classification systems for allergic rhi-
nitis (AR) severity, whose are used to guide treatment.
Clinical observation suggests that ARIA method, made
by doctors, and visual analogic scale of symptoms
(VASS), made by patients, do not obtain the same
results in many occasions. The aim of this study was to
compare the results of these methods applied at the
same time in a cohort of adolescents and adults with
AR under specialized outpatient care.
Methods
Retrospective study of clinical records of patients with AR
in treatment between March-2011 and August-2012 at an
university hospital in Rio de Janeiro/Brazil, where both
classifications have been used routinely since 2010. Four
hundred clinical sheets were reviewed, we excluded
patients under 12 years old, without at least one cutaneos
test positive to aeroallergens and those with incorrect clin-
ical data. Kappa coefficient (Stata 11) was used to measure
agreement between them using 2 (mild and moderate/
severe), 3 (mild, moderate and severe) and 6 categories
(also considering intermittent and persistent grades),
according to original and modified ARIA classifications.
Results
We included clinical records of 124 patients: 88 were
women (71%), the median age was 39 years (perc25-
75=17-55) and 77 (62%) had associated asthma. Using
ARIA modificated method (ARIAm - Valero at al. 2007),
they were classified as mild=55 (44.3%), moderate=56
(45.1%) and severe=13 (10.4%). Using VASS, patients clas-
sified themselves as mild=35 (28.2%), moderate=68
(54.8%) and severe=21 (16.9%). Kappa analysis in the
entire sample showed low agreement at 2, 3 or 6 compari-
son levels between the classifications (k=0.30, 0.39 and
0.37, respectively). The classifications were different in 51
(41.1%) patients when we compared 3 level of severity
with lower agreements at 3 or 6 levels of comparison in
females, in patients older than 18 years and in those with
associated asthma. Better concordance was achieved in
patients younger than 18 years (substantial), in patients
without asthma (moderate) and in males (moderate).
Conclusions
Our findings suggest that many patients have a different
perception of severity of their disease using VASS when
compared with results from ARIA classification, with a low
to moderate concordance between the two methods. Pre-
sence of asthma, age and gender seems to influence these
results. Large studies comparing the outcomes using both
methods to guide treatment may help us to define the bet-
ter one to make therapeutic decisions in clinical practice.
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